Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lyne

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
CNS Spectrums|January 31, 2009
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHDJ Biederman, Raun D Melmed, Anil Patel, et al.
Pediatrics|January 2, 2008
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorderJoseph Biederman, Raun D Melmed, Anil Patel, et al.
CNS Drugs|November 9, 2015
Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled TrialMark A Stein, Vanja Sikirica, Margaret D Weiss, et al.
Science (New York, N.Y.)|November 2, 2013
Evolution of the magnetic field structure of the Crab pulsarAndrew Lyne, Francis Graham-Smith, Patrick Weltevrede, et al.
CNS Drugs|September 3, 2010
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trialDaniel F Connor, Robert L Findling, Scott H Kollins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 20, 2011
A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorderTimothy E Wilens, Oscar Bukstein, Matthew Brams, et al.
Journal of Child and Adolescent Psychopharmacology|April 12, 2011
Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorderScott H Kollins, Frank A López, Bradley D Vince, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2015
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity DisorderTimothy E Wilens, Brigitte Robertson, Vanja Sikirica, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trialAmaia Hervas, Michael Huss, Mats Johnson, et al.
Science (New York, N.Y.)|September 7, 2019
Radio emission from a pulsar's magnetic pole revealed by general relativityGregory Desvignes, Michael Kramer, Kejia Lee, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
CNS Spectrums|January 31, 2009
Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHDJ Biederman, Raun D Melmed, Anil Patel, et al.
Pediatrics|January 2, 2008
A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorderJoseph Biederman, Raun D Melmed, Anil Patel, et al.
CNS Drugs|November 9, 2015
Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled TrialMark A Stein, Vanja Sikirica, Margaret D Weiss, et al.
Science (New York, N.Y.)|November 2, 2013
Evolution of the magnetic field structure of the Crab pulsarAndrew Lyne, Francis Graham-Smith, Patrick Weltevrede, et al.
CNS Drugs|September 3, 2010
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trialDaniel F Connor, Robert L Findling, Scott H Kollins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 20, 2011
A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorderTimothy E Wilens, Oscar Bukstein, Matthew Brams, et al.
Journal of Child and Adolescent Psychopharmacology|April 12, 2011
Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorderScott H Kollins, Frank A López, Bradley D Vince, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2015
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity DisorderTimothy E Wilens, Brigitte Robertson, Vanja Sikirica, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2014
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trialAmaia Hervas, Michael Huss, Mats Johnson, et al.
Science (New York, N.Y.)|September 7, 2019
Radio emission from a pulsar's magnetic pole revealed by general relativityGregory Desvignes, Michael Kramer, Kejia Lee, et al.
Pageof 3